Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Artemether-lumefantrine surveillance study for uncomplicated falciparum malaria in Lao PDR
ACTRN12610000935033Phase 4Terminated
- Sponsor
- Ministry of Health
- Start
- Jul 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of artemether + lumefantrine in malaria and Falciparum malaria (PF), sponsored by Ministry of Health. Primary endpoint: 28-day cure rate (ACPR). Started Jul 2010; status: terminated.
02
Drugs
artemether + lumefantrine
03
Conditions
malariaFalciparum malaria (PF)
Beyond the preview
Go deeper on ACTRN12610000935033.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12610000935033.